Cafepharma Today

January 31 2025 - AbbVie earnings: Analyst weighs in on drug pipeline, HHS hearing
AbbVie earnings: Analyst weighs in on drug pipeline, HHS hearing
Europe to review safety data for Eisai-Biogen Alzheimer's drug
Novartis posts better-than-expected fourth-quarter sales
Vertex’s non-opioid pain drug gets FDA approval in milestone for company and research
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Avalon gets warning, hunts for cash
Fierce Biotech
Wednesday, April 8, 2009 - 9:30am
tags:
Avalon, cancer
Eli Lilly Drops The F In The UK
CNBC
Wednesday, April 8, 2009 - 9:28am
tags:
Eli Lilly, UK, Effient, blood thinners, Plavix
Glaxo's Avandia Issue Priced-In
Yahoo/Zacks.com
Wednesday, April 8, 2009 - 9:26am
tags:
GSK, Avandia
Pfizer in Name, Wy-Pfi in Spirit?
InVivo
Wednesday, April 8, 2009 - 8:33am
tags:
Pfizer, Wyeth, reorganization
Somaxon Provides Update on New Drug Application for Silenor® (doxepin) for the Treatment of Insomnia
Yahoo
Wednesday, April 8, 2009 - 8:31am
tags:
Somaxon, Silenor, FDA, insomnia
FDA panel to consider weight gain and heart risk versus benefits of Seroquel for depression
Yahoo/AP
Wednesday, April 8, 2009 - 8:30am
tags:
FDA, Seroquel, AstraZeneca, depression, schizophrenia
Lundbeck Drug Not Backed for Broad Schizophrenia Use
Bloomberg
Wednesday, April 8, 2009 - 8:29am
tags:
Lundbeck, schizophrenia, Serdolect
Medivation Prostate Cancer Drug Blocks Tumor Protein
Bloomberg
Wednesday, April 8, 2009 - 8:29am
tags:
Medivation, prostate cancer
Why Is Biogen Idec on the Rise?
Seeking Alpha
Wednesday, April 8, 2009 - 8:05am
tags:
Biogen Idec
J&J Warns Against Quick Approvals for Biotech Copies
Bloomberg
Tuesday, April 7, 2009 - 9:51pm
tags:
JNJ, drug approvals, patents, generics
More Prescriptions for Generics, Fewer for Branded Drugs
WSJ Online
Tuesday, April 7, 2009 - 9:50pm
tags:
generics, prescription data
Pfizer's Mind Meld
Motley Fool
Tuesday, April 7, 2009 - 6:20pm
tags:
Pfizer, Wyeth, Amgen, Merck, Schering Plough
Epix says it may file for bankruptcy protection
Yahoo/AP
Tuesday, April 7, 2009 - 6:17pm
tags:
Epix
Pharmaceutical Winners and Losers: Eli Lilly
TheStreet.com
Tuesday, April 7, 2009 - 6:15pm
tags:
Pfizer, Eli Lilly, Wyeth, GSK, Proctor & Gamble, Bristol-Myers Squibb
Bristol-Myers Squibb: On the Patent Cliff's Edge
Motley Fool
Tuesday, April 7, 2009 - 6:14pm
tags:
patents, Bristol-Myers Squibb, Plavix, Sanofi
Novartis to Invest More in China; Cut Back Operations in US
Trading Markets
Tuesday, April 7, 2009 - 11:23am
tags:
Novartis, China
Reorganizing Pharma R&D: $62 Billion Merger Not Required
WSJ Online
Tuesday, April 7, 2009 - 11:21am
tags:
R&D
AP Pharma gets Nasdaq delisting warning
Bizjournals.com
Tuesday, April 7, 2009 - 11:20am
tags:
AP Pharma, NASDAQ
Cougar Biotech Initiated at Hold
Yahoo/Zacks.com
Tuesday, April 7, 2009 - 11:19am
tags:
Cougar Biotechnology, oncology
Amylin Staunchly Defends Byetta
TheStreet.com
Tuesday, April 7, 2009 - 11:18am
tags:
Amylin, diabetes, Byetta

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

Unlocking AI’s Promise in Patient Support Programs
Drug Channels
Right There At the Electrode
In the Pipeline
Annoying Enzyme Activity
In the Pipeline
Drug Channels News Roundup, January 2025: Mark Cuban Fixes Healthcare, Payers’ G2N Bubble, Pharmacists Rejoice, 340B Shenanigans, and 46Brooklyn vs. Mushrooms
Drug Channels
Bacteria (and Their Metabolites) and Depression
In the Pipeline
Some Good MASH/NASH News For Once
In the Pipeline
Attacking Estrogen-Receptor-Positive Breast Cancer
In the Pipeline
New Study Reveals Five Crucial Priorities Shaping The Future of Patient Services
Drug Channels
Killing Cancer Patients (Once the Payments Clear)
In the Pipeline

Latest Jobs

Sr. Training Manager Learning & Performance- Commercial Sales
Yardley, Pennsylvania, United States
EVERSANA
Psychiatry Account Manager - Midland, TX
Midland, Texas, US
Lundbeck
Psychiatry Account Manager - Newport News, VA
Newport News, Virginia, US
Lundbeck
Psychiatry Account Manager - Saint Louis South, MO
Saint Louis, Missouri, US
Lundbeck
Psychiatry Account Manager - Macon, GA
Macon, Georgia, US
Lundbeck
Psychiatry Account Manager - Plano, TX
Plano, Texas, US
Lundbeck
Psychiatry Account Manager - College Station, TX
College Station, Texas, US
Lundbeck
Pharmaceutical Sales Representative- Associate Territory Manager- Cardiometabolic Health
Tallahassee, Florida
Eli Lilly and Company
Manager, Associates Membership Sales
Alexandria, Virginia, United States
Health Industry Distributors Association
Pharmaceutical Sales Representative - Associate Territory Manager, Cardiometabolic Health
Jacksonville, Florida
Eli Lilly and Company
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information